← Leaderboards
Nduka Mgbechinyere Amankulor
University Of Pennsylvania
$2,082,285
Attributed
$2,082,285
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $710.1K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,082,285 · 1
By mechanism
R37$2,082,285 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Stephen G Emerson$28,932,839
- Daniel James Rader$77,348,993
- Daniel Patrick Kelly$33,087,106
- Lewis A Chodosh$38,386,361
- Charles P Emerson$35,198,488
Others in their field
Other Rising Stars on “Antibodies”
- Jason Dickens · Duke University$12,259,409
- Jeff T Hutchins · Inhalon Biopharma, Inc.$11,188,896
- Robert C Alexander · Banner Health$8,197,111
- Shaunna Shen · Duke University$7,747,008
- Li Liang · University Of California-Irvine$7,511,446
- Bruxanne El-Kammash · University Of Chicago$7,281,050
Research focus
AntibodiesBiological MarkersBloodBrainBrain NeoplasmsCd4 Positive T LymphocytesCd8b1 GeneCd8-Positive T-LymphocytesCellsCell TypeCessation Of LifeCheckpoint InhibitionChemotherapy And/Or RadiationClinical EfficacyClinical TrialsCohortCombined Modality TherapyDesignDiffuseDisease RemissionDoseEpigenetic ProcessEpigenetic SilencingAdjuvant
Grant awards (3)
Interrogating Mechanisms of Anti-tumor Immunity in Human Subjects and Murine Models of IDH-Mutant Glioma Treated with All-Trans Retinoic Acid and PD-1 Inhibition$710,142
R37 · FY2025 · CA · contact PI
Interrogating Mechanisms of Anti-tumor Immunity in Human Subjects and Murine Models of IDH-Mutant Glioma Treated with All-Trans Retinoic Acid and PD-1 Inhibition$689,044
R37 · FY2024 · CA · contact PI
Interrogating Mechanisms of Anti-tumor Immunity in Human Subjects and Murine Models of IDH-Mutant Glioma Treated with All-Trans Retinoic Acid and PD-1 Inhibition$683,099
R37 · FY2023 · CA · contact PI